交易 Novo Nordisk AS ADR - NVO 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.11
• 长仓隔夜仓息调整: -0.02157%
• 短仓隔夜仓息调整: -0.00065%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: USD
• 最低成交量: 0.1
• 保证金: 5.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 35.95
• 开仓: 35.11
• 1 年变化: -49.23%
• 日区间: 35.08 - 35.51

交易 Novo Nordisk AS ADR - NVO 差价合约

Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries and markets its products in more than 170 countries worldwide. The company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. Operating through two business segments, including diabetes and obesity care, and biopharmaceuticals. The company’s diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The company’s biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk’s insulin and other pharmaceutical products are marketed and distributed through subsidiaries, distributors and independent agents with responsibility for specific geographical areas. With Capital.com you stay in sync with the latest info on the Novo Nordisk (NVO) share price.